Eris Lifesciences Quarterly Results for Trading Insights

ERIS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹135 Cr
QSept 2025
Quarterly Results

Eris Lifesciences Quarterly Results Key Highlights

  • Revenue of ₹793 Cr in Sept 2025 (+11.5% vs Mar 2025, +6.6% vs Sept 2024)
  • Net Profit of ₹135 Cr in Sept 2025 (+32.4% vs Mar 2025, +40.6% vs Sept 2024)
  • EBITDA of ₹289 Cr in Sept 2025 (+12.0% vs Mar 2025)
  • Operating Margin of 36.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹8.82 in Sept 2025 (+27.8% vs Mar 2025)

Eris Lifesciences Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 793 711 775 801 744 11.5% 6.6%
Net Profit (₹ Cr) 135 102 125 109 96 - -
EBITDA (₹ Cr) 289 258 279 258 267 - -
EPS (₹) 8.82 6.90 8.66 7.32 6.73 - -
Operating Margin (%) 36.0% 36.0% 36.0% 32.0% 35.0% - -

Eris Lifesciences Share Price Trend Around Quarterly Results

Visualize Eris Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Eris Lifesciences

Additional stock information and data for ERIS

ERIS company profile
ERIS P/E ratio
ERIS 52-week high low

Profitability Ratios

Profit Margin 17.0%
EBITDA Margin 36.4%
Operating Margin 36.0%
ROE (Annual) 16.5%

Balance Sheet Highlights

Total Assets ₹7,033 Cr
Total Equity ₹3,272 Cr
Current Assets ₹1,223 Cr
Current Liabilities ₹2,380 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,065 Cr
Investing Cash Flow ₹-78 Cr
Financing Cash Flow ₹-881 Cr
Net Cash Flow ₹106 Cr

Current Market Data

Current Price ₹1297.20
Exchange NSE
Last Updated Mar 30, 2026

Revenue Trend (₹ Cr)

Dec 2025 801
Jun 2025 775
Mar 2025 711
Sept 2025 793

Net Profit Trend (₹ Cr)

Dec 2025 109
Jun 2025 125
Mar 2025 102
Sept 2025 135

Operating Margin Trend (%)

Dec 2025 32.0%
Jun 2025 36.0%
Mar 2025 36.0%
Sept 2025 36.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Eris Lifesciences quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1757.2 14,875 3,125 +10.8% - 21.0% 135.2
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5947.0 2,860 689 +7.1% - 24.1% 229.0
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 4220.2 3,219 591 +11.3% - 18.4% 240.6
Lupin
Sept 2025 		₹107,238.09 Cr 2313.9 6,921 1,485 +23.2% - 21.5% 71.5
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1254.9 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores